Henry Schein Inc
$ 78.19
-0.31%
13 Feb - close price
- Market Cap 9,511,081,000 USD
- Current Price $ 78.19
- High / Low $ 79.58 / 77.47
- Stock P/E 24.74
- Book Value 28.35
- EPS 3.17
- Next Earning Report 2026-02-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 82.80
- 52 Week Low 60.56
About
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Analyst Target Price
$78.14
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 | 2023-05-09 | 2023-02-16 |
| Reported EPS | 1.38 | 1.1 | 1.15 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 | 1.21 | 1.21 |
| Estimated EPS | 1.28 | 1.19 | 1.1101 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 | 1.23 | 1.21 |
| Surprise | 0.1 | -0.09 | 0.0399 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 | -0.02 | 0 |
| Surprise Percentage | 7.8125% | -7.563% | 3.5943% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% | -1.626% | 0% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.3 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2026-02-11 14:27:34
Healthcare continues to struggle with interoperability in 2026, posing significant challenges for implementing new technologies like AI and achieving a holistic view of patient care. Experts suggest strategies to overcome these issues, including improving data quality at the source, connecting to health information exchanges (HIEs), and widely adopting industry standards such as FHIR and USCDI. These efforts aim to bridge data silos, enhance data access for clinicians, and ensure that technological advancements benefit all communities, not just the affluent.
2026-02-11 09:28:28
The global dental impression systems market, valued at USD 1.85 billion in 2025, is projected to reach USD 3.30 billion by 2034, growing at a CAGR of 6.7%. This growth is driven by increasing demand for dental treatments, technological advancements, and a significant shift from traditional to digital impression systems. Key market players like Dentsply Sirona and Align Technology are focusing on innovation and strategic partnerships to capitalize on these opportunities.
2026-02-10 16:38:25
Henry Schein is opening a new 8,300-square-foot Dallas Discovery Center in Southlake, Texas, on March 4, 2026. This facility will serve as a collaborative hub for dental and medical equipment, training, and innovation, bridging the gap between oral and overall health. The center will offer healthcare professionals a hands-on environment to explore advancements and enhance patient care.
2026-02-09 04:33:29
Henry Schein (HSIC) is facing competitive pressures, with its organic revenue growth and returns on capital shrinking. Despite a "most popular narrative" suggesting it's 2% overvalued at $79.72 against a fair value of $78.14, its P/E ratio at 24x earnings indicates it trades above the US Healthcare group but below its own fair ratio and peer average. The article encourages investors to analyze their own assumptions and offers tools to build a custom view of the company.
2026-02-07 03:57:56
Henry Schein (HSIC) stock has reached a 52-week high of $80.66 USD, currently trading at $81.03, just below its peak of $82.38. This surge is supported by aggressive share buybacks by management and investor confidence in its business model, despite a slight 1-year decline. Upcoming earnings on February 24, new CEO appointment, and strategic distribution agreements are key factors for investors to watch.
2026-02-07 02:57:59
Henry Schein Inc. (HSIC) stock has hit a 52-week high of $80.66, with its current price at $81.03, just below its peak. The company, with a market capitalization of $9.47 billion and a "GOOD" financial health rating, has shown resilience and investor confidence. Upcoming earnings on February 24, a new distribution agreement, and a new CEO appointment are key recent developments.
